We proposed that a subset of the immunopeptidome consists of tumour-specific peptides derived from essential oncoproteins and that these can be targeted using synthetic PC-CARs
Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity
G.NavaP.LeeW
GHK-Cu bezporednio stymuluje fibroblasty (komrki produkujce kolagen) do wzmoonej syntezy: Kolagenu typu I , gwnego biaka strukturalnego skry, cigien, wizade (+70 % w badaniach Maquart 1988) Kolagenu typu III , bardziej elastycznego typu dla tkanek regeneracyjnych Elastyny , biaka odpowiedzialnego za elastyczno skry Dekoryny i glikozaminoglikanw , hialuronianu, siarczanu dermatanu W dziedzinie dermatologii tumaczy to efekt przeciwzmarszczkowy GHK-Cu, przywrcenie struktury kolagenowej skry, ktra sabnie z wiekiem